Menarini Group presents new and expanded data at the 2024 San Antonio Breast Cancer Symposium in patients with ER+, HER2- advanced or metastatic breast cancer. Read today’s press release here: https://bit.ly/4fLfGSp
Menarini Stemline’s Post
More Relevant Posts
-
In this webinar, we discuss the importance of biomarker testing for therapeutic implications in metastatic breast cancer. Register to hear patient cases where #biomarker testing contributed to tailored treatment strategies in the setting of metastatic breast cancer: https://lnkd.in/dcS5_7Ky #MetastaticBreastCancer
-
-
In this webinar, we discuss the importance of biomarker testing for therapeutic implications in metastatic breast cancer. Register to hear patient cases where #biomarker testing contributed to tailored treatment strategies in the setting of metastatic breast cancer: https://lnkd.in/esfYBm3S #MetastaticBreastCancer
-
-
In this webinar, we discuss the importance of biomarker testing for therapeutic implications in metastatic breast cancer. Register to hear patient cases where #biomarker testing contributed to tailored treatment strategies in the setting of metastatic breast cancer: https://lnkd.in/gCEKgWq2 #MetastaticBreastCancer
-
-
One of the main themes at this year’s San Antonio Breast Cancer Symposium was SERDs (selective estrogen receptor degraders) in both early stage and metastatic breast cancer. In this video, I talk about what they are, how they work and how we are using them- and ongoing clinical trials. #breastcancer #serd #sabcs24
-
Central Laboratory Services | Non-Clinical | Clinical Phase I-IV | Preclinical | Early Development | Business Development | Inside Sales
In this webinar, we discuss the importance of biomarker testing for therapeutic implications in metastatic breast cancer. Register to hear patient cases where #biomarker testing contributed to tailored treatment strategies in the setting of metastatic breast cancer: https://lnkd.in/dy-Asra8 #MetastaticBreastCancer
-
-
In this webinar, we discuss the importance of biomarker testing for therapeutic implications in metastatic breast cancer. Register to hear patient cases where #biomarker testing contributed to tailored treatment strategies in the setting of metastatic breast cancer: https://lnkd.in/grRfwGGu #MetastaticBreastCancer
-
-
Precision Medicine I Pharma/Biotech I Global Strategic Partnering I Biomarker Discovery I Drug Development I Clinical Trials I Oncology Therapeutics I Cell & Gene Therapy I Companion Diagnostics Commercialization
In this webinar, we discuss the importance of biomarker testing for therapeutic implications in metastatic breast cancer. Register to hear patient cases where #biomarker testing contributed to tailored treatment strategies in the setting of metastatic breast cancer: https://lnkd.in/eEuccUU2 #MetastaticBreastCancer
-
-
Precision Medicine I Pharma/Biotech I Global Strategic Partnering I Biomarker Discovery I Drug Development I Clinical Trials I Oncology Therapeutics I Cell & Gene Therapy I Companion Diagnostics Commercialization
In this webinar, we discuss the importance of biomarker testing for therapeutic implications in metastatic breast cancer. Register to hear patient cases where #biomarker testing contributed to tailored treatment strategies in the setting of metastatic breast cancer: https://lnkd.in/eEuccUU2 #MetastaticBreastCancer
-
-
In this webinar, we discuss the importance of biomarker testing for therapeutic implications in metastatic breast cancer. Register to hear patient cases where #biomarker testing contributed to tailored treatment strategies in the setting of metastatic breast cancer: https://lnkd.in/gpGbWKCQ #MetastaticBreastCancer
-
-
In this webinar, we discuss the importance of biomarker testing for therapeutic implications in metastatic breast cancer. Register to hear patient cases where #biomarker testing contributed to tailored treatment strategies in the setting of metastatic breast cancer: https://lnkd.in/eQ-YqMGW #MetastaticBreastCancer
-
